Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P3.01-081 Overall Survival (OS) of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) After Negative Invasive Mediastinal Staging

Journal of Thoracic Oncology

English

MS11.01 Identifying Consequences of Stigma on Lung Cancer Care Delivery and Patient Outcomes

Journal of Thoracic Oncology

English

P2.01-02 Osimertinib for EGFR-Positive Advanced NSCLC With Brain Metastases: Preliminary Analysis of an Open-Label, Two-Arm, Phase 2 Study

Journal of Thoracic Oncology

English

P1.09-28 Clinical Utility of Rapid Immunohistochemistry for Differentiation of Solitary Pulmonary Adenocarcinomas

Journal of Thoracic Oncology

English

Cysteine- Rich Secretory Protein 3 (CRISP3), ERG and PTEN Define a Molecular Subtype of Prostate Cancer With Implication to Patients’ Prognosis

Journal of Hematology and Oncology

English

Targeted Nanoconjugate Co-Delivering siRNA and Tyrosine Kinase Inhibitor to Kras Mutant NSCLC Reveals Gab1 Assisted Survival Pathway Post Oncogene Knockdown

Journal of Thoracic Oncology

English

Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient With MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

Journal of Thoracic Oncology

English

OA03.02 Nationwide Comparative Study of PD-L1 IHC Assays on Lung Cancer: Initial Report of LC-SCRUM-IBIS Project

Journal of Thoracic Oncology

English

P1.01-10 Stage III Non-Small Cell Lung Cancer Clinical Outcomes With Surgical Resection After Definitive Neoadjuvant Chemoradiotherapy

Journal of Thoracic Oncology

English

P1.03-20 the Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P3.01-081 Overall Survival (OS) of Locally Advanced Non-Small Cell Lung Cancer (NSCLC) After Negative Invasive Mediastinal Staging

MS11.01 Identifying Consequences of Stigma on Lung Cancer Care Delivery and Patient Outcomes

P2.01-02 Osimertinib for EGFR-Positive Advanced NSCLC With Brain Metastases: Preliminary Analysis of an Open-Label, Two-Arm, Phase 2 Study

P1.09-28 Clinical Utility of Rapid Immunohistochemistry for Differentiation of Solitary Pulmonary Adenocarcinomas

Cysteine- Rich Secretory Protein 3 (CRISP3), ERG and PTEN Define a Molecular Subtype of Prostate Cancer With Implication to Patients’ Prognosis

Targeted Nanoconjugate Co-Delivering siRNA and Tyrosine Kinase Inhibitor to Kras Mutant NSCLC Reveals Gab1 Assisted Survival Pathway Post Oncogene Knockdown

Response to Dual Crizotinib and Osimertinib Treatment in a Lung Cancer Patient With MET Amplification Detected by Liquid Biopsy Who Acquired Secondary Resistance to EGFR Tyrosine Kinase Inhibition

OA03.02 Nationwide Comparative Study of PD-L1 IHC Assays on Lung Cancer: Initial Report of LC-SCRUM-IBIS Project

P1.01-10 Stage III Non-Small Cell Lung Cancer Clinical Outcomes With Surgical Resection After Definitive Neoadjuvant Chemoradiotherapy

P1.03-20 the Novel SFN Inhibitors Aprepitant and Ticagrelor Exert Anti-Tumor Effects Through Blocking of Oncoprotein Ubiquitination